High-salt diet and hypertension: Focus on the renin-angiotensin system

Kidney and Blood Pressure Research

Volumn 34, Issue 1, 2011, Pages 1-11

  Drenjacnevic Peric, I ^a   Jelakovic B ^b   Lombard, J H ^c   Kunert, M P ^c   Kibel, A ^a   Gros, M ^a  

^a JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^b KBC Zagreb   (Croatia)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Hypertension; Renin angiotensin system; Salt; Sodium

Indexed keywords

CYTOKINE PRODUCTION; DISEASE MODEL; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANIMALS; BLOOD PRESSURE; DIET, SODIUM-RESTRICTED; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SODIUM, DIETARY;

EID: 78149355625     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320387     Document Type: Review

References (122)

1. Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, SchmieDer RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, Mc- Gregor K, Sechtem U, Silber S, TenDera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Po nikowski P, Redon J, Ruschitzka F, Tamargo J, Van Zwieten P, Waeber B, Williams B: 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
2. World Health Organization: Fact Sheet: The Top Ten Causes Of Death. Fact sheet No. 310. Geneva, WHO, 2008.
3. World Health Organization: The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, WHO, 2002.
4. Murray CJL, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223.
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration: Age-specific releVance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913.
7. Vasan RS, Larson MG, Leip EP, EVans JC, O'Donnell CJ, Kannel WB, Levy D: Impact of high normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297.
8. Wolf-Maier K, Cooper RJS, Banegas JR, Giampaoli S, Hense H-W, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F: Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003; 289: 2363-2369.
9. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlies P: The burden of adult hypertension in the United States 1999 to 2000. A rising tide. Hypertension 2004; 44: 398-404.
10. Fuentes R, Ilmaniemi N, Laurikainen E, Tuomilehto J, Nissinen A: Hypertension in developing economies: a review of population- based studies carried out from 1980 to 1998. J Hypertens 2000; 18: 521-529.
11. Jelakoviæ B, Zeljkoviæ-Vrkiæ T, Peæin I, Dika Z, JoVanoviæ A, Podobnik D, Smuc T, Gamberger D, Katiæ K, Kasner M, Kuzmaniæ D: Arterial hypertension in Croatia. Results of EH-UH study. Acta Med Croatica 2007; 61: 287-292.
12. Zdrojewski T, Szpakowski P, Bandosz P, Pajak A, Wiszcek A, Krupa-Wojciechowska, Wyrzykowski B: Arterial hypertension in Poland in 2002. J Hum Hypertension 2004; 18: 557-562.
13. Primatesta P, Poulter NR: Improvement in hypertension management in England: results from the Health Survey for England 2003. J Hypertens 2006; 24: 1187-1192.
14. Giampaoli S, Palmieri L, Dima F, Pilotto L, Vescio MF, Vanuzzo D: Socioeconomic aspects and cardiovascular risk factors: experience at the Cardiovascular Epidemiologic Observatory. Ital Heart J 2001; 2: 294-302.
15. Banages JR, Rodriguez-Artalejo F, de la Cruz Trosca JJ, Guallar-Castillo P, del Rey Calero J: Blood pressure in Spain. Distribution, awareness, control and benefits of a reduction in average pressure. Hypertension 1998; 32: 998-1002.
16. Thamm M: Blood pressure in Germany: current status and trends. Gesundheitswesen 1999; 61:S90-S93.
17. Stegmayr B, Harmsen P, Rajakangas A, Rastenyte D, Sarti C, Thorvaldsen P, Tuomilehto J: Stroke around the Baltic Sea: incidence, case fatality and population risk factors in Denmark, Finland, Sweden, and Lithuania. Cerebrovasc Dis 1996; 6: 80-88.
18. Kastarinen M, Antikainen R, Peltonen M, Laatikainen T, Barengo NC, Jula A, Salomaa V, Jousilahti P, Nissinen A, Vartiainen E, Tuomilehto J: Prevalence, awareness and treatment of hypertension in Finland during 1982-2007. J Hypertens 2009; 27: 1552-1559.
19. Zdrojewski T, Pienkowski R, Szynkiewicz M, Krupa-Wojcjechowska B: Have rapid socioeconomic changes influenced awareness of blood pressure in Poland? J Hum Hypertension 2001; 15: 247-253.
20. Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A: High blood pressure and associated cardiovascular risk factors in France. J Hypertens 2001; 19: 1727-1732.
21. Cifkova R, Škodova Z, Lanska V, Adamkova V, Novozamska E, Petržlikova Z, Jozífová M, Plásková M, Hejl Z, Palous D, Galovcová M: Trends in blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2000/01. J Hypertens 2004; 22: 1479-1485.
22. Riecansky I, Egnerova A: Cardiovascular program in Slovakia. Results achieved over the years 1978-1989. Bratisl Lek Listy 1991; 92: 203-218.
23. Dorobantu M, Bãdilã E, Ghiorghe S, Darabont RO, Olteanu M, Flondor P: Total cardiovascular risk estimation in Romania. Data from the SEPHAR study. Rom J Intern Med 2008; 46: 29-37.
24. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA: Arterial pressure regulation: overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972; 52: 584-594.
25. Guyton AC: Blood pressure control: special role of the kidneys and body fluids. Science 1991; 252: 1813-1816.
26. Rodriguez-Iturbe B, Vaziri ND: Salt-sensitive hypertension - update on novel findings. Nephrol Dial Transplant 2007; 22: 992-995.
27. Julius S: Transition from high cardiac output to elevated vascular resistance in hypertension. Am Heart J 1988; 116: 600-606.
28. Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, Adair TH: Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 1998; 31: 1083-1087. (Pubitemid 28191501)
29. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning RD Jr: Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2006; 291:R1817-R1824.
30. Gu JW, Young E, Pan ZJ, Tucker KB, Shparago M, Huang M, Bailey AP: Long-term high salt diet causes hypertension and alters renal cytokine gene expression profiles in Sprague-Dawley rats. Beijing Da Xue Xue Bao 2009; 41: 505-515.
31. Gu JW, Bailey AP, Tan W, Shparago M, Young E: Long-term high salt diet causes hypertension and decreases renal expression of vascular endothelial growth factor in Sprague-Dawley rats. J Am Soc Hypertens 2008; 2: 275-285.
32. Gu JW, Manning RD Jr, Young E, Shparago M, Sartin B, Bailey AP: Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 2009; 297:R142-R148.
33. James G, Baker T: Human population biology and blood pressure: evolutionary and ecological consiDeration and interpretations of population studies; in Laragh JH, Brenner BM (eds): Hypertension, Diagnosis and Management, ed 2. New York, Raven Press, 1995, pp 115-135.
34. Carvalho J, Baruzzi R, Howard P, Poulter P, Alpers M, Franco LJ, Marcopito LF, Spooner VJ, Dyer AR, Elliott P: Blood pressure in four remote populations in the Intersalt study. Hypertension 1989; 14: 238-246. (Pubitemid 19219999)
35. Weinberger MH: Salt sensitivity of blood pressure in humans. Hypertension 1996; 27: 481-490.
36. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297: 319-328.
37. Cutler JA, Follmann D, AllenDer PS: Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997; 65(Suppl 2):643S- 651S.
38. Kempner W: Treatment of hypertensive vascular disease with rice diet. Am J Med 1948; 4: 545-577.
39. Sacks F, Svetkey L, Vollmer W, Appel L, Bray G, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344: 3-10. (Pubitemid 32064838)
40. He J, Ogden L, Vupputuri S, Bazzano L, Loria C, Whelton P: Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. J Am Med Assoc 1999; 282: 2027-2034.
41. Hajjar I, Grim C, George V, Kotchen T: Impact of diet on blood pressure and age-related changes in blood pressure in the US population. Analysis of NHANES III. Arch Intern Med 2001; 161: 589-593.
42. Appel L, Espeland M, Easter L, Wilson A, Folmar S, Lacy C: Effects of reduced sodium intake on hypertension control in olDer individuals. Results from the Trial of Nonpharmacological Interventions in the ElDerly (TONE). Arch Intern Med 2001; 161: 685-693.
43. Kojuri J, Rahimi R: Effect of 'no added salt diet' on blood pressure control and 24 h urinary sodium excretion in mild to moDerate hypertension. BMC Cardiovasc Disord 2007; 7: 34.
44. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook SW, Williams B, Ford GA: Lifestyle interventions to reduce raised blood pressure: a systematic review of randomised controlled trials. J Hypertens 2006; 24: 215-233.
45. Graudal NA, Galloe AM, Garred P: Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279: 1383-1391.
46. He FJ, MacGregor GA: How far should salt intake be reduced? Hypertension 2003; 42: 1093-1099.
47. Robertson JIJ: Dietary salt and hypertension: a scientific issue or a matter of faith? J Eval Clin Pract 2003; 9: 1-22.
48. Australian National Health and Medical Research Council, Dietary Salt Study Management Committee: Effects of replacing sodium intake in subjects on a low sodium diet: crossover study. Clin Exp Hypertens 1989;A11: 1011-1024.
49. Jürgens G, Graudal NA: Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database Syst Rev 2004;(1):CD004022.
50. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK: Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885.
51. Baudouin M, Meyer P, Worcel M: Specific binding of 3H-angiotensin II in rabbit aorta. Biochem Biophys Res Commun 1971; 42: 434-440.
52. Devynck MA, Pernollet MG, Meyer P, Fermandjian S, Fromageot P: Angiotensin receptors in smooth muscle cell membranes. Nat New Biol 1973; 245: 55-58.
53. Tigerstedt R, Bergman PG: Niere und Kreislauf. Skand Arch Physiol 1988; 8: 223.
54. Tobian L, Tomboulian A, Janecek J: The effect of high perfusion pressure on the granulation of juxtaglomerular cells in an isolated kidney. J Clin Invest 1959; 38: 605-610.
55. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S: Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA 1983; 80: 2196-2200. (Pubitemid 13097161)
56. Skeggs LT, Marsh WH, Kahn JR, Shumway NP: The existence of two forms of hypertension. J Exp Med 1954; 99: 275-282.
57. Unger T, Stoppelhaar M: Rationale for double renin-angiotensin- aldosterone system blockade. Am J Cardiol 2007; 100: 25J-31J.
58. Van Esch JH, Oosterveer CR, Batenburg WW, Van Veghel R, Jan Danser AH: Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor? Eur J Pharmacol 2008; 588(2- 3):286-293.
59. Yang R, SmolDers I, De Bundel D, Fouyn R, Halberg M, Demaegdt H, VanDerheyden P, Dupont AG: Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat. J Hypertens 2008; 26: 998-1007.
60. Danilczyk U, Penninger JM: Angiotensinconverting enzyme II in the heart and the kidney. Circulation Res 2006; 98: 463-471.
61. Williams GH, Hollenberg NK: Sodium-sensitive essential hypertension: emerging insights into an old entity. J Am Coll Nutr 1989; 8: 490-494.
62. Franco V, Oparil S: Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 2006; 25(Suppl 3):247S-255S.
63. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8:II127- II134.
64. Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R: Surgical menopause increases salt sensitivity of blood pressure. Hypertension 2006; 47: 1168-1174.
65. Hasimu B, Nakayama T, Mizutani Y, Izumi Y, Asai S, Soma M, Kokubun S, Ozawa Y: Haplotype analysis of the human renin gene and essential hypertension. Hypertension 2003; 41: 308-312.
66. Giner V, Poch E, Bragulat E, Oriola J, Gonzalez D, Coca A, De la Sierra A: Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 2000; 35: 512-517.
67. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de la Sierra A: Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001; 38: 1204-1209.
68. Zhang L, Miyaki K, Araki J, Song Y, Kimura T, Omae K, et al.: Interaction of angiotensin I-converting enzyme insertion-deletion polymorphism and daily salt intake influences hypertension in Japanese men. Hypertens Res 2006; 29: 751-758.
69. Rose P, Bond J, Tighe S, Toth MJ, Wellman TL, Briso de Montiano EM, Lewinter MM, Lounsbury KM: Genes overexpressed in cerebral arteries following salt-induced hypertensive disease are regulated by angiotensin II, JunB, and CREB. Am J Physiol Heart Circ Physiol 2008; 294:H1075-H1085.
70. Weinberger MH: Racial differences in renal sodium excretion: relationship to hypertension. Am J Kidney Dis 1993; 21(4 Suppl 1):41-45.
71. Hertz RP, Unger AN, Cornell JA, SaunDers E: Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165: 2098-2104.
72. Luft FC, Miller JZ, Grim CE, Fineberg NS, Christian JC, Daugherty SA, Weinberger MH: Salt sensitivity and resistance of blood pressure. Age and race as factors in physiological responses. Hypertension 1991; 17(Suppl 1):I102-I108.
73. Richardson AD, Piepho RW: Effect of race on hypertension and antihypertensive therapy. Int J Clin Pharmacol Ther 2000; 38: 75-79.
74. Jamerson KA: Rationale for angiotensin II receptor blockers in patients with low-renin hypertension. Am J Kidney Dis 2000; 36(3 Suppl 1):S24-S30.
75. Strehlow K, Nickenig G, Roeling J, Wassmann S, Zolk O, Knorr A, Böhm M: AT(1) receptor regulation in salt-sensitive hypertension. Am J Physiol 1999; 277:H1701-H1707.
76. Wang DH, Du Y: Regulation of vascular type 1 angiotensin II receptor in hypertension and sodium loading: role of angiotensin II. J Hypertens 1998; 16: 467-475.
77. Stewen P, Mervaala E, Karppanen H, Nyman T, Saijonmaa O, Tikkanen I, Fyhrquist F: Sodium load increases renal angiotensin type 1 receptors and decreases bradykinin type 2 receptors. Hypertens Res 2003; 26: 583-589.
78. Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL: Alterations in aldosterone and angiotensin II levels in salt-induced hypertension. Clin Exp Hypertens 2005; 27: 355-367.
79. Kopkan L, Cervenka L: Renal interactions of renin-angiotensin system, nitric oxide and superoxide anion: implications in the pathophysiology of salt-sensitivity and hypertension. Physiol Res 2009; 58(Suppl 2):S55-S67.
80. Husková Z, Kramer HJ, Vanourková Z, Cervenka L: Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats. J Hypertens 2006; 24: 517-527.
81. Husková Z, Kramer H, Vanourková Z, Thumová M, Malý J, Opocenský M, Skaroupková P, Kolský A, Vernerová Z, Cervenka L: Effects of dietary salt load and salt depletion on the course of hypertension and angiotensin II levels in male and female heterozygous Ren-2 transgenic rats. Kidney Blood Press Res 2007; 30: 45-55.
82. De La Sierra A, Lluch MM, Coca A, Aguilera MT, Giner V, Bragulat E, Urbano-Márquez A: Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients. Clin Sci 1996; 91: 155-161.
83. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-Derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468-1474.
84. Panza JA, Casino PR, Badar DM, Quyyumi AA: Effect of increased availability of endothelium- Derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993; 87: 1475-1481.
85. Panza JA, Quyyumi AA, Callahan TS, Epstein SE: Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 1993; 21: 1145-1151.
86. Bragulat E, de la SA, Antonio MT, Coca A: Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension 2001; 37: 444-448.
87. Zhou MS, Adam AG, Jaimes EA, Raij L: In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II. Hypertension 2003; 42: 945-951.
88. Zhou MS, Hernandez Schulman I, Pagano PJ, Jaimes EA, Raij L: Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006; 47: 81-86.
89. Schulman IH, Zhou MS, Raij L: Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl 2006; 24:S45-S50.
90. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S, Hara K, Matsuura H, Chayama K, Oshima T: Sodium chloride loading does not alter endothelium-dependent vasodilation of forearm vasculature in either salt-sensitive or salt-resistant patients with essential hypertension. Hypertens Res 2001; 24: 711-716.
91. Dishy V, Sofowora GG, Imamura H, Nishimi Y, Xie HG, Wood AJ, Stein CM: Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responses. J Hypertens 2003; 21: 153-157.
92. dos Santos L, Gonçalves MV, Vassallo DV, Oliveira EM, Rossoni LV: Effects of high sodium intake diet on the vascular reactivity to phenylephrine on rat isolated caudal and renal vascular beds: endothelial modulation. Life Sci 2006; 78: 2272-2279.
93. Yu H, Di Nicolantonio R: Altered nuclear protein binding to the first intron of the renin gene of the spontaneously hypertensive rat. Clin Exp Hypertens 1998; 20: 817-832.
94. Rapp JP, Wang SM, Dene H: A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989; 243: 542-544.
95. Leckie BJ: Polymorphisms of the renin gene promoter in spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 2001; 28: 60-63.
96. Di Nicolantonio R, Lan L, Wilks A: Nucleotide variations in intron 1 of the renin gene of the spontaneously hypertensive rat. Clin Exp Hypertens 1998; 20: 27-40.
97. Cowley AW Jr, Stoll M, Greene AS, Kaldunski ML, Roman RJ, Tonellato PJ, Schork NJ, Dumas P, Jacob HJ: Genetically defined risk of salt sensitivity in an intercross of Brown Norway and SS rats. Physiol Genomics 2000; 2: 107-115.
98. Cowley AW Jr, Roman RJ, Kaldunski ML, Dumas P, Dickhout JG, Greene AS, Jacob HJ: Brown Norway chromosome 13 confers protection from high salt to consomic SS rat. Hypertension 2001; 37: 456-461.
99. Roman RJ, Cowley AW Jr, Greene A, Kwitek AE, Tonellato PJ, Jacob HJ: Consomic rats for the identification of genes and pathways unDerlying cardiovascular disease. Cold Spring Harb Symp Quant Biol 2002; 67: 309-315.
100. Cowley AW Jr, Liang M, Roman RJ, Greene AS, Jacob HJ: Consomic rat model systems for physiological genomics. Acta Physiol Scand 2004; 181: 585-592.
101. Drenjancevic-Peric I, Frisbee JC, Lombard JH: Skeletal muscle arteriolar reactivity in SS.BN13 consomic rats and Dahl salt-sensitive rats. Hypertension 2003; 41: 1012-1015.
102. Drenjancevic-Peric I, Lombard JH: Introgression of chromosome 13 in Dahl saltsensitive genetic background restores cerebral vascular relaxation. Am J Physiol Heart Circ Physiol 2004; 287:H957-H962.
103. Drenjancevic-Peric I, Greene AS, Kunert MP, Lombard JH: Arteriolar responses to vasodilator stimuli and elevated P(O2) in renin congenic and Dahl salt-sensitive rats. Microcirculation 2004; 11: 669-677.
104. Drenjancevic-Peric I, Phillips SA, Falck JR, Lombard JH: Restoration of normal vascular relaxation mechanisms in cerebral arteries by chromosomal substitution in consomic SS.13BN rats. Am J Physiol Heart Circ Physiol 2005; 289:H188-H195.
105. Drenjancevic-Peric I, Weinberg BD, Greene AS, Lombard JH: Restoration of cerebral vascular relaxation in renin congenic rats by introgression of the Dahl R renin gene. Am J Hypertens 2010; 23: 243-248.
106. Lenda DM, Sauls BA, Boegehold MA: Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol 2000; 279:H7-H14.
107. Lenda DM, Boegehold MA: Effect of a highsalt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol 2002; 282:H395-H402.
108. Zhu J, Huang T, Lombard JH: Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res 2007; 44: 382-390.
109. Weber DS, Lombard JH: Elevated salt intake impairs dilation of rat skeletal muscle resistance arteries via ANG II suppression. Am J Physiol Heart Circ Physiol 2000; 278:H500-H506.
110. Weber DS, Lombard JH: Angiotensin II AT1 receptors preserve vasodilator reactivity in skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 2001; 280:H2196-H2202.
111. Phillips SA, Lombard JH: Chronic At1 receptor blockade alters the mechanisms mediating hypoxic dilation in middle cerebral arteries. J Cardiovasc Pharmacol 2005; 46: 706-712.
112. Koga Y, Hirooka Y, Araki S, Nozoe M, Kishi T, Sunagawa K: High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens Res 2008; 31: 2075-2083.
113. Adams JM, McCarthy JJ, Stocker SD: Excess dietary salt alters angiotensinergic regulation of neurons in the rostral ventrolateral medulla. Hypertension 2008; 52: 932-937.
114. Yemane H, Busauskas M, Burris SK, Knuepfer MM: Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Exp Physiol 2010; 95: 51-55.
115. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R: The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1: 1009-1016.
116. Dell'Omo G, Penno G, Pucci L, Lucchesi D, Del Prato S, Pedrinelli R: Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men. Nephrol Dial Transplant 2009; 24: 1864-1869.
117. BorDer WA, Noble NA: Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 1998; 31: 181-188.
118. Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG: Aldosterone/ salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 2003; 63: 1791-1800.
119. Luft FC: Transforming growth factor betaangiotensin II interaction: implications for cardiac and renal disease. J Mol Med 1999; 77: 517-518.
120. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM: TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008; 294:R76-R83.
121. Nonaka-Sarukawa M, Okada T, Ito T, Yamamoto K, Yoshioka T, Nomoto T, Hojo Y, Shimpo M, Urabe M, Mizukami H, Kume A, Ikeda U, Shimada K, Ozawa K: Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J Gene Med 2008; 10: 368-374.
122. Katori M, Majima M: A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci 2006; 100: 370-390.